US SB1505 | 2019-2020 | 116th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on May 16 2019 - 25% progression, died in committee
Action: 2019-05-16 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Requires prescription drug plan sponsors to report any suspicious activities relating to fraud, waste, or abuse under the Medicare prescription drug benefit and any corrective actions taken.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Medicare Prescription Drug Fraud Prevention Act of 2019

Sponsors


History

DateChamberAction
2019-05-16SenateRead twice and referred to the Committee on Finance.

Same As/Similar To

SB3129 (Related) 2019-12-19 - Read twice and referred to the Committee on Finance.
SB2543 (Related) 2019-09-25 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 225.
SB4199 (Related) 2020-07-02 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4228)

Subjects


US Congress State Sources


Bill Comments

feedback